Study of Rhopressa ® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

Conditions:   Glaucoma, Open-Angle;   Ocular Hypertension Intervention:   Drug: Netarsudil Ophthalmic Solution 0.02% Sponsor:   Aerie Pharmaceuticals Recruiting

Source: ClinicalTrials.gov - January 17, 2019 Category: Research Source Type: clinical trials